% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Prasuhn:180804,
author = {J. Prasuhn and M. Göttlich and S. S. Großer and K.
Reuther and B. Ebeling and C. Bodemann and H. Hanssen and A.
Nagel$^*$ and N. Brüggemann},
title = {{I}ncreased {S}ubcortical {S}odium {L}evels in {P}atients
with {P}rogressive {S}upranuclear {P}alsy.},
journal = {Biomedicines},
volume = {10},
number = {7},
issn = {2227-9059},
address = {Basel},
publisher = {MDPI},
reportid = {DKFZ-2022-01566},
pages = {1728},
year = {2022},
abstract = {Progressive supranuclear palsy (PSP) is a debilitating
neurodegenerative disease characterized by an aggressive
disease course. Total and intracellular-weighted sodium
imaging (23Na-MRI) is a promising method for investigating
neurodegeneration in vivo. We enrolled 10 patients with PSP
and 20 age- and gender-matched healthy control subjects; all
study subjects underwent a neurological examination,
whole-brain structural, and (total and
intracellular-weighted) 23Na-MRI. Voxel-wise analyses
revealed increased brainstem total sodium content in PSP
that correlated with disease severity. The ROI-wise analysis
highlighted additional sodium level changes in other regions
implicated in the pathophysiology of PSP. 23Na-MRI yields
substantial benefits for the diagnostic workup of patients
with PSP and adds complementary information on the
underlying neurodegenerative tissue changes in PSP.},
keywords = {23Na-MRI (Other) / PSP (Other) / heteronuclear MRI (Other)
/ neurodegeneration (Other) / progressive supranuclear palsy
(Other)},
cin = {E020},
ddc = {570},
cid = {I:(DE-He78)E020-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:35885033},
doi = {10.3390/biomedicines10071728},
url = {https://inrepo02.dkfz.de/record/180804},
}